Fifth Scientific Conference of the IRRF
The International Radiosurgery Research Foundation will hold its next scientific meeting—presented by the IRRF and Baptist Health South Florida--at the Ritz-Carlton Hotel Coconut Grove in Miami, Fla., October 27-29, 2023. Below is the preliminary meeting agenda. This agenda is subject to change.
Friday, October 27, 2023
12:00-5:00 pm
Industry User Sessions
5:00-7:30 pm
IRRF Board Meeting/Dinner
Saturday, October 28, 2023
7:30-7:40 am
Welcome & Introductions – Manmeet Ahluwalia/Jason Sheehan/Ajay Niranjan
Session I – Brain Tumors I
7:40-7:50 am
Optimal dose planning for brain metastases control
7:50- 8:10 am
Immunotherapy and SRS
8:10-8:25 am
Targeted therapy for brain metastases and SRS
8:25-8:40 am
Complementary therapies to SRS (review of LITT, intraoperative radiotherapy, FUS)
8:40-8:55 am
Medical and surgical management of radiation necrosis (surgery, steroids, Avastin, LITT)
8:55-9:10 am
Management of recurrent brain metastases (could include repeat SRS, LITT, surgery, gamma-tile
9:10-9:30 am
Q&A
9:30-9:45 am
Break
Session II – Primary Tumors
9:45-9:55 am
When enough is enough: Leaving Residual Meningioma or Vestibular Schwannoma at Surgery
9:55-10:05 am
Predicting and Treating Post-SRS Edema in Meningioma
10:05-10:15 am
Managing grade 2-3 meningioma
10:15-10:25 am
Timing of SRS in VS
10:25-10:35 am
NF2 VS and SRS
10:25-10:45 am
Panel Discussion for Meningiomas and Schwannomas
10:45-10:55 am
SRS in Recurrent HGG
10:55-11:05 am
LITT for HGG
11:05-11:15 am
Emerging Strategies for Gliomas
11:15-11:35 am
Panel Discussion Gliomas
11:40 am-12:00 pm
Keynote Talk
12:00-1:00 pm
Lunch Break
Session III - Big Data and Clinical Trials
1:00-1:15 pm
Imaging Artificial Intelligence/Machine-learning in Prediction of Response Following SRS
1:15-1:30 pm
Use of Registries in Assessing Clinical Efficacy of SRS
1:30-1:45 pm
Spatial Modeling and Prediction of Metastases Topography
1:45-2:00 pm
Radiomics and Radiosurgery
2:00-2:30 pm
AI for Radiation Planning
2:30-2:45 pm
Panel Discussion
2:45-3:00 pm
Break
Session IV – Brain Tumors II
3:00-3:15 pm
Physics of Radiosurgery and Brachytherapy
3:15-3:45 pm
Fractionated SRS
3:45-4:00 pm
Staged/Adaptive SRS
4:00:4:15 pm
Resection and Post-operative WBRT
4:15-4:30 pm
Resection and Post-operative Brachytherapy
4:30-4:45 pm
Resection and Post-operative SRS
4:45-5:00 pm
Pre-operative SRS and Resection
5:00-5:10 pm
Panel Discussion
20 Keynote Talk
5:10-5:30 pm
Keynote Talk
5:30 pm
Adjourn
6:00-8:00 pm
Conference Dinner
Sunday, October 29, 2023
Session V – Vascular Indications
8:00-8:15 am
Large AVMs – Multi-Stage SRS
8:15-8:30 am
Dural AVFs and SRS
8:30-8:45 am
Physics of Staged SRS
8:45-9:00 am
Embolization Before or After SRS
9:00-9:15 am
Cavernomas and SRS
9:15-9:30 am
Aneurysm and SRS
9:30-9:45 am
Unruptured AVMs: Evidence and Contemporary Management
9:45-10:00 am
Peri- and Intranidal Aneurysms Associated with AVMs
10:00-10:15 am
Panel Discussion
10:15-10:30 am
Break
Session VI – Functional
10:30-10:45 am
BED in Trigeminal Neuralgia
10:45-11:00 am
Tremor and SRS in the World of DBS and FUS
11:00-11:15 am
OCD
11:15-11:30 am
Non-CN V Pain Treated with SRS
11:30-11:45 am
Validated Assessments for TGN
11:55 am-12:00 pm
Hypothalamic Hamartomas and Epilepsy
12:00-12:15 pm
Q&A
12:15-12:30 pm
Conference Wrap Up
This is the preliminary program and is subject to change.
Friday, October 27, 2023
12:00-5:00 pm
Industry User Sessions
5:00-7:30 pm
IRRF Board Meeting/Dinner
Saturday, October 28, 2023
7:30-7:40 am
Welcome & Introductions – Manmeet Ahluwalia/Jason Sheehan/Ajay Niranjan
Session I – Brain Tumors I
7:40-7:50 am
Optimal dose planning for brain metastases control
7:50- 8:10 am
Immunotherapy and SRS
8:10-8:25 am
Targeted therapy for brain metastases and SRS
8:25-8:40 am
Complementary therapies to SRS (review of LITT, intraoperative radiotherapy, FUS)
8:40-8:55 am
Medical and surgical management of radiation necrosis (surgery, steroids, Avastin, LITT)
8:55-9:10 am
Management of recurrent brain metastases (could include repeat SRS, LITT, surgery, gamma-tile
9:10-9:30 am
Q&A
9:30-9:45 am
Break
Session II – Primary Tumors
9:45-9:55 am
When enough is enough: Leaving Residual Meningioma or Vestibular Schwannoma at Surgery
9:55-10:05 am
Predicting and Treating Post-SRS Edema in Meningioma
10:05-10:15 am
Managing grade 2-3 meningioma
10:15-10:25 am
Timing of SRS in VS
10:25-10:35 am
NF2 VS and SRS
10:25-10:45 am
Panel Discussion for Meningiomas and Schwannomas
10:45-10:55 am
SRS in Recurrent HGG
10:55-11:05 am
LITT for HGG
11:05-11:15 am
Emerging Strategies for Gliomas
11:15-11:35 am
Panel Discussion Gliomas
11:40 am-12:00 pm
Keynote Talk
12:00-1:00 pm
Lunch Break
Session III - Big Data and Clinical Trials
1:00-1:15 pm
Imaging Artificial Intelligence/Machine-learning in Prediction of Response Following SRS
1:15-1:30 pm
Use of Registries in Assessing Clinical Efficacy of SRS
1:30-1:45 pm
Spatial Modeling and Prediction of Metastases Topography
1:45-2:00 pm
Radiomics and Radiosurgery
2:00-2:30 pm
AI for Radiation Planning
2:30-2:45 pm
Panel Discussion
2:45-3:00 pm
Break
Session IV – Brain Tumors II
3:00-3:15 pm
Physics of Radiosurgery and Brachytherapy
3:15-3:45 pm
Fractionated SRS
3:45-4:00 pm
Staged/Adaptive SRS
4:00:4:15 pm
Resection and Post-operative WBRT
4:15-4:30 pm
Resection and Post-operative Brachytherapy
4:30-4:45 pm
Resection and Post-operative SRS
4:45-5:00 pm
Pre-operative SRS and Resection
5:00-5:10 pm
Panel Discussion
20 Keynote Talk
5:10-5:30 pm
Keynote Talk
5:30 pm
Adjourn
6:00-8:00 pm
Conference Dinner
Sunday, October 29, 2023
Session V – Vascular Indications
8:00-8:15 am
Large AVMs – Multi-Stage SRS
8:15-8:30 am
Dural AVFs and SRS
8:30-8:45 am
Physics of Staged SRS
8:45-9:00 am
Embolization Before or After SRS
9:00-9:15 am
Cavernomas and SRS
9:15-9:30 am
Aneurysm and SRS
9:30-9:45 am
Unruptured AVMs: Evidence and Contemporary Management
9:45-10:00 am
Peri- and Intranidal Aneurysms Associated with AVMs
10:00-10:15 am
Panel Discussion
10:15-10:30 am
Break
Session VI – Functional
10:30-10:45 am
BED in Trigeminal Neuralgia
10:45-11:00 am
Tremor and SRS in the World of DBS and FUS
11:00-11:15 am
OCD
11:15-11:30 am
Non-CN V Pain Treated with SRS
11:30-11:45 am
Validated Assessments for TGN
11:55 am-12:00 pm
Hypothalamic Hamartomas and Epilepsy
12:00-12:15 pm
Q&A
12:15-12:30 pm
Conference Wrap Up
This is the preliminary program and is subject to change.